|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||0.00 - 0.00|
|Beta (5Y monthly)||1.20|
|PE ratio (TTM)||N/A|
|Earnings date||08 Feb 2023 - 13 Feb 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
The nature of investing is that you win some, and you lose some. Unfortunately, shareholders of Ultragenyx...
Ultragenyx (RARE) reports a wider-than-expected loss in the third quarter. Revenues, though up year over year, miss estimates.
Ultragenyx (RARE) delivered earnings and revenue surprises of -6.11% and 8.16%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?